ArticleJournal of Cancer2014

Geldanamycin and Its Derivatives Inhibit the Growth of Myeloma Cells and Reduce the Expression of the MET Receptor.

Artur Jurczyszyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.